Trial Profile
A phase III Open label Randomized study to compare the efficacy of Lenalidomide - Rituximab (LR) vs Bendamustine â??Rituximab (BR) in treatment naïve follicular lymphoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Bendamustine; Rituximab
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 31 Aug 2016 New trial record